KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Revenue (2017 - 2025)

Historic Revenue for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $52.0 million.

  • Cardlytics' Revenue fell 2240.78% to $52.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.2 million, marking a year-over-year decrease of 1441.15%. This contributed to the annual value of $278.3 million for FY2024, which is 999.53% down from last year.
  • According to the latest figures from Q3 2025, Cardlytics' Revenue is $52.0 million, which was down 2240.78% from $63.2 million recorded in Q2 2025.
  • Over the past 5 years, Cardlytics' Revenue peaked at $90.0 million during Q4 2021, and registered a low of $52.0 million during Q3 2025.
  • For the 5-year period, Cardlytics' Revenue averaged around $70.0 million, with its median value being $67.9 million (2022).
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 10853.59% in 2021, then tumbled by 2240.78% in 2025.
  • Over the past 5 years, Cardlytics' Revenue (Quarter) stood at $90.0 million in 2021, then decreased by 8.38% to $82.5 million in 2022, then grew by 8.08% to $89.2 million in 2023, then dropped by 17.01% to $74.0 million in 2024, then decreased by 29.68% to $52.0 million in 2025.
  • Its Revenue stands at $52.0 million for Q3 2025, versus $63.2 million for Q2 2025 and $61.9 million for Q1 2025.